Altered Rheological Properties of Blood following Administrations of Tissue Plasminogen Activator and Streptokinase in Patients with Acute Myocardial Infarction
Tissue blood flow is determined by rheological properties of blood as well as by vascular resistance. In acute myocardial infarction patients who participated in the TIMI I trial, we compared the effects of recombinant tissue plasminogen activator (rt-PA) and streptokinase (SK) on blood rheological properties and plasma fibrinogen concentration. Blood viscosity was determined by using a coaxial cylinder viscometer at shear rates, γ, of 0.01-200 sec-1. Red blood cell (RBC) deformability was studied by filtration through poly-carbonate microsieves with pore size of 3 and 5 μm. Therapy with rt-PA resulted in slight decreases but statistically significant in blood viscosity from 5.2±0.5 to 4.9±0.4 cP (γ = 52 sec-1), plasma viscosity from 1.36±0.09 to 1.32±0.06 cP, and plasma fibrinogen from 0.26 ± 0.04 to 0.21 ±0.03 g/dl. SK therapy resulted in reductions in blood viscosity from 5.1 ± 0.5 to 4.6 ± 0.3 cP, plasma viscosity from 1.26 ± 0.10 to 1.16 ± 0.03 cP, and fibrinogen from 0.26 ± 0.06 to 0.10 ± 0.05 g/dl. Changes observed with SK were significantly greater than those observed with rt-PA (all p <0.05), and the differences persisted at 10 days after thrombolytic therapy. RBC deformability was similar in the two groups. The greater reduction of blood viscosity after SK than rt-PA suggests that, for a given degree of arterial patency, myocardial blood flow may be better maintained with SK than rt-PA in patients with acute myocardial infarction.
KeywordsShear Rate Acute Myocardial Infarction Myocardial Blood Flow Thrombolytic Therapy Blood Viscosity
Unable to display preview. Download preview PDF.
- 3.The TIMI Study Group. The thrombolysis in myocardial infarction (TIMI) trial: Phase I findings. N. Engl. J. Med., 312:932 (1985).Google Scholar
- 4.Gruppo Italiano per lo Studio della Streptochinasi nell’Infarto Miocardico (GISSI): Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction. Lancet, 1:397 (1986).Google Scholar
- 6.G. V. Martin, M. L. Stadius, K. B. Davis, J. L. Ritchie, F. K. Sheehan, C. Maynard, and J. W. Kennedy. The Western Washington intravenous streptokinase trial; effects of intravenous streptokinase on vessel patency and left ventricular function. Circulation, 74 (Suppl II):II-367 (1986).Google Scholar
- 8.S. Chien. Biophysical behavior of red cells in suspension. In: D. M. Surgenor, editor: The Red Blood Cells, 2nd edition, New York, 1975, Academic Press, vol 2, p. 1031.Google Scholar
- 12.F. H. Sheehan, E. Braunwald, P. Canner, H. T. Dodge, J. Gore, P. Van Natta, E. R. Passamani, D. O. William, and B. Zaret. The effect of intravenous thrombolytic therapy on left ventricular function: a report on tissue plasminogen activator and streptokinase from the Thrombolysis in Myocardial Infarction (TIMI Phase I) trial. Circulation, 75:817 (1987).PubMedCrossRefGoogle Scholar
- 13.J. H. Chesebro, G. Knatterud, R. Roberts, J. Borer, L. S. Cohen, J. Dalen, H. T. Dodge, C. K. Francis, D. Hillis, P. Ludbrook J. E. Markis, H. Hueller, E. R. Passamani, E. R. Powers, A. K. Rao, T. Robertson, A. Ross, T. J. Ryan, B. E. Sobel, J. Willerson, D. O. Williams, B. L. Zaret, and E. Braunwald. Thrombolysis in Myocardial Infarction (TIMI) trial, Phase I: a comparison between intravenous plasminogen activator and intravenous streptokinase. Clinical findings through hospital discharge. Circulation, 76:142 (1987).PubMedCrossRefGoogle Scholar
- 14.A. K. Rao, C. Pratt, A. Berke, A. Jaffe, I. Ockene, T. L. Schreiber, W. R. Bell, G. Knatterud, T. L. Robertson, and M. L. Terrin. Thrombolysis in Myocardial Infarction (TIMI) trial - Phase I: hemorrhagic manifestations and changes in plasma fibrinogen and the fibrinolytic system in patients treated with recombinant tissue plasminogen activator and streptokinase. J. Am. Coll. Cardiol., 11:1 (1988).PubMedCrossRefGoogle Scholar
- 16.B. S. Neuhausen, and D. M. Rioch. The refractometric determination of serum protein. J. Biol. Chem., 55:353 (1923).Google Scholar
- 22.S. Chien. Blood rheology and its relation to flow resistance and transcapillary exchange, with special reference to shock. Advances in Microcir.,2:89 (1969).Google Scholar
- 24.I. Weinberger, J. Fuchs, A. Tobul, Z. Rotenberg, and J. Agmon. Plasma viscosity changes during acute myocardial infarction. Circulation, 72(Suppl III)::III-417 (1985).Google Scholar
- 27.The European Cooperative Study Group. Streptokinase in acute myocardial infarction extended report of the European Cooperative Trial. Acta. Med. Scand, Supple, 648:7 (1981).Google Scholar
- 32.A. M. Ehrly. Rheological changes due to fibrinolytic therapy. In: K. Messmer, H. Schmid-Schönbein, editor: Hemodilution. Theoretical Basis and Clinical Application. Basel, 1972, S. Karger, p. 289.Google Scholar